Changing paradigms in dermatology: Proteomics: A new approach to skin disease

Clinics in Dermatology

Volumn 21, Issue 5, 2003, Pages 370-374

  Goldstein, Adrian M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

CELL FUNCTION; CLINICAL TRIAL; ECZEMA; GENE IDENTIFICATION; GENE SEQUENCE; GENE TARGETING; GENOMICS; HUMAN; IMMUNE SYSTEM; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEOMICS; PSORIASIS; REVIEW; SKIN DISEASE;

EID: 0346218245     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2003.08.014     Document Type: Article

References (31)

1. Kestel J. Treatment of actinic keratosis. Arch Dermatol. 102:1970;351.
2. Standaert R.F., Galat A., Verdine G.L., et al. Molecular cloning and overexpression of the human FK506-binding protein FKBP. Nature. 346:1990;671-674.
3. McCaffrey P.G., Perrino B.A., Soderling T.R., et al. NF-ATp, a T lymphocyte DNA-binding protein that is a target for calcineurin and immunosuppressive drugs. J Biol Chem. 268:1993;3747-3752.
4. Bos J.D., Wierenga E.A., Sillevis Smitt J.H., et al. Immune dysregulation in atopic eczema. Arch Dermatol. 128:1992;1509-1512.
5. Lander E.S., Linton L.M., Birren B., et al. Initial sequencing and analysis of the human genome. Nature. 409:2001;860-921.
6. Venter J.C., Adams M.D., Myers E.W., et al. The sequence of the human genome. Science. 291:2001;1304-1351.
7. The human genome. Science genome map. Science 2001;291:1218.
8. Soto C., Saborio G.P. Prions disease propagation and disease therapy by conformational transmission . Trends Mol Med. 7:2001;109-114.
9. Neubauer G., King A., Rappsilber J., et al. Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex. Nat Genet. 20:1998;46-50.
10. Rout M.P., Aitchison J.D., Suprapto A., et al. The yeast nuclear pore complex composition, architecture, and transport mechanism . J Cell Biol. 148:2000;635-651.
11. Peltier J.B., Friso G., Kalume D.E., et al. Proteomics of the chloroplast systematic identification and targeting analysis of lumenal and peripheral thylakoid proteins . Plant Cell. 12:2000;319-341.
12. Fields S., Song O. A novel genetic system to detect protein-protein interactions. Nature. 340:1989;245-246.
13. Legrain P., Wojcik J., Gauthier J.M. Protein-protein interaction maps a lead towards cellular functions . Trends Genet. 17:2001;346-352.
14. Rain J.C., Selig L., De Reuse H., et al. The protein-protein interaction map of Helicobacter pylori. Nature. 409:2001;211-215.
15. Uetz P., Giot L., Cagney G., et al. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature. 403:2000;623-627.
16. Fromont-Racine M., Rain J.C., Legrain P. Toward a functional analysis of the yeast genome through exhaustive two-hybrid screens. Nat Genet. 16:1997;277-282.
17. Walhout A.J., Sordella R., Lu X., et al. Protein interaction mapping in C. elegans using proteins involved in vulval development. Science. 287:2000;116-122.
18. Stewart D.M., Tian L., Nelson D.L. Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein. J Immunol. 162:1999;5019-5024.
19. Mamiya N., Worman H.J. Hepatitis C virus core protein binds to a DEAD box RNA helicase. J Biol Chem. 274:1999;15751-15756.
20. Holbert S., Denghien I., Kiechle T., et al. The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis . Proc Natl Acad Sci USA. 98:2001;1811-1816.
21. Bartel P.L., Roecklein J.A., SenGupta D., et al. A protein linkage map of Escherichia coli bacteriophage T7. Nat Genet. 12:1996;72-77.
22. McCraith S., Holtzman T., Moss B., et al. Genome-wide analysis of vaccinia virus protein-protein interactions. Proc Natl Acad Sci USA. 97:2000;4879-4884.
23. Ito T., Chiba T., Ozawa R., et al. A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci USA. 98:2001;4569-4574.
24. + (thymocyte-like) T lymphocytes present in blood and skin from patients with atopic dermatitis suggest immune dysregulation. Br J Dermatol. 144:2001;1140-1147.
25. Prinz J.C. Psoriasis vulgaris - a sterile antibacterial skin reaction mediated by cross-reactive T cells? An immunological view of the pathophysiology of psoriasis. Clin Exp Dermatol. 26:2001;326-332.
26. Fearon U., Veale D.J. Pathogenesis of psoriatic arthritis. Clin Exp Dermatol. 26:2001;333-337.
27. Burg G., Dummer R., Haeffner A., et al. From inflammation to neoplasia mycosis fungoides evolves from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumors . Arch Dermatol. 137:2001;949-952.
28. Thomson A.W., Bonham C.A., Zeevi A. Mode of action of tacrolimus (FK506) molecular and cellular mechanisms . Ther Drug Monit. 17:1995;584-591.
29. Liu W., Youn H.D., Zhou X.Z., et al. Binding and regulation of the transcription factor NFAT by the peptidyl prolyl cis-trans isomerase Pin1. FEBS Lett. 496:2001;105-108.
30. Yang X.Y., Wang L.H., Chen T., et al. Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARγ) agonists. PPARgamma co-association with transcription factor NFAT. J Biol Chem. 275:2000;4541-4544.
31. Bassuk A.G., Anandappa R.T., Leiden J.M. Physical interactions between Ets and NF-κB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells. J Virol. 71:1997;3563-3573.